Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 31, 2015 8:38 PM ET

Pharmaceuticals

Company Overview of Embera NeuroTherapeutics, Inc.

Company Overview

Embera NeuroTherapeutics, Inc., a development-stage pharmaceutical company, develops treatments for smoking cessation, cocaine dependence, and other addictions. It engages in developing EMB-001, an addiction treatment that includes benzodiazepine oxazepam and cortisol synthesis inhibitor metyrapone medications, which targets the stress response system and specific brain functions that leads to craving and relapse associated with these disorders, as well as acts by modulating various stress-related pathways to reduce the craving that drives addictions. The company was founded in 2005 and is based in Sudbury, Massachusetts.

29 Babe Ruth Drive

Sudbury, MA 01776

United States

Founded in 2005

Phone:

318-213-0198

Fax:

419-844-4459

Key Executives for Embera NeuroTherapeutics, Inc.

Chief Executive Officer, President and Director
Founder and Chief Scientific Officer
Chief Medical Officer
Vice President of Business Strategy and Development
Vice President of Pre-Clinical Development and Regulatory Affairs
Compensation as of Fiscal Year 2015.

Embera NeuroTherapeutics, Inc. Key Developments

Embera NeuroTherapeutics, Inc. Presents at BIO International Convention 2015, Jun-16-2015 04:45 PM

Embera NeuroTherapeutics, Inc. Presents at BIO International Convention 2015, Jun-16-2015 04:45 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Michael J. Detke, Chief Medical Officer.

Embera NeuroTherapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 10:00 AM

Embera NeuroTherapeutics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 10:00 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Embera NeuroTherapeutics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

Embera NeuroTherapeutics, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

Similar Private Companies By Industry

Company Name Region
Antipodean Pharmaceuticals, Inc United States
Lundbeck Inc. United States
Cardero Therapeutics, Inc. United States
Natural Biosciences, Inc. United States
Neuraltus Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 19, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Embera NeuroTherapeutics, Inc., please visit emberaneuro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.